Fifth Lane Capital LP Reduces Stock Position in M3-Brigade Acquisition V Corp. $MBAV

Fifth Lane Capital LP reduced its holdings in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) by 15.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 279,606 shares of the company’s stock after selling 50,000 shares during the period. M3-Brigade Acquisition V makes up about 2.6% of Fifth Lane Capital LP’s investment portfolio, making the stock its 10th largest position. Fifth Lane Capital LP owned about 0.78% of M3-Brigade Acquisition V worth $2,950,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Sandia Investment Management LP bought a new position in M3-Brigade Acquisition V during the second quarter valued at about $334,000. Clear Street LLC increased its position in shares of M3-Brigade Acquisition V by 2,280.8% during the second quarter. Clear Street LLC now owns 32,069 shares of the company’s stock valued at $362,000 after purchasing an additional 30,722 shares during the period. Levin Capital Strategies L.P. bought a new stake in shares of M3-Brigade Acquisition V during the second quarter valued at approximately $538,000. Bluefin Capital Management LLC acquired a new position in shares of M3-Brigade Acquisition V in the second quarter valued at $690,000. Finally, JPMorgan Chase & Co. bought a new position in M3-Brigade Acquisition V in the second quarter worth $900,000.

M3-Brigade Acquisition V Price Performance

M3-Brigade Acquisition V stock opened at $10.71 on Friday. The business’s fifty day moving average is $10.67 and its two-hundred day moving average is $10.61. M3-Brigade Acquisition V Corp. has a 52 week low of $10.16 and a 52 week high of $13.73.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research note on Monday, December 22nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has an average rating of “Sell”.

Insider Activity at M3-Brigade Acquisition V

In other news, major shareholder Fitzgerald & Co. Cantor purchased 3,529,081 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The shares were acquired at an average price of $10.80 per share, for a total transaction of $38,114,074.80. Following the completion of the acquisition, the insider directly owned 7,779,865 shares in the company, valued at approximately $84,022,542. The trade was a 83.02% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

M3-Brigade Acquisition V Profile

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.